Company Monitoring Page for Boehringer-Ingelheim

latest headlines for company on cafepharma

Boehringer wins EU approval for Humira biosimilar
BioPharma Dive
Wed, 11/15/17 - 08:53 pm
Tags:
Boehringer Ingelheim, Europe, Humira, biosimilars, Cyltezo, AbbVie
GlaxoSmithKline's Anoro tops Boehringer's Stiolto in head-to-head COPD tilt
Fierce Pharma
Sat, 11/4/17 - 08:44 am
Tags:
GSK, Anoro Ellipta, Boehringer Ingelheim, Stiolto Respimat, COPD
Dicerna and Boehringer partner on RNAi treatment for NASH
Endpoints
Thu, 11/2/17 - 11:14 am
Tags:
Dicerna, Boehringer Ingelheim, NASH, RNAi
Boehringer Ingelheim, Anthem partner for largest real-world COPD trial
Drug Delivery Business News
Thu, 10/12/17 - 10:19 pm
Tags:
Boehringer Ingelheim, Anthem, COPD
Boehringer's new risk-prediction model will tap patients who could be good Jardiance candidates
Fierce Pharma
Wed, 09/27/17 - 11:19 am
Tags:
Boehringer Ingelheim, Eli Lilly, Jardiance, diabetes
EASD: Boehringer Ingelheim, Lilly's Jardiance holds CV benefit regardless of blood sugar starting point
Fierce Pharma
Thu, 09/14/17 - 11:27 am
Tags:
EASD, Boehringer Ingelheim, Eli Lilly, Jardiance, diabetes
Boehringer Ingelheim/Pharmaxis start Phase IIa trial in NASH
GoInPharma
Wed, 08/30/17 - 11:45 pm
Tags:
Boehringer Ingelheim, Pharmaxis, NASH, clinical trials, BI 1467335
CVS formulary knocks Lilly, BI's Jardiance in favor of J&J's Invokana
Fierce Pharma
Wed, 08/2/17 - 11:57 am
Tags:
formulary, Eli Lilly, Boehringer Ingelheim, JNJ, Invokana, diabetes, CVS Caremark
J&J's Invokana continues downward market-share spiral as Lilly, BI's Jardiance advances
Fierce Pharma
Wed, 07/19/17 - 07:47 pm
Tags:
JNJ, Invokana, Eli Lilly, Boehringer Ingelheim, Jardiance, diabetes
This Secretive Clan Wants to Beat the World’s Biggest Drugmakers
Bloomberg
Mon, 07/17/17 - 09:50 pm
Tags:
Boehringer Ingelheim
Key Humira patent gets struck down for the second time in as many months
Fierce Pharma
Sun, 07/9/17 - 11:38 am
Tags:
Humira, patents, AbbVie, Boehringer Ingelheim, Coherus Biosciences
BI, Lilly hit the streets to talk up Jardiance's cardiovascular benefits
Fierce Pharma
Wed, 06/28/17 - 10:13 am
Tags:
Boehringer Ingelheim, Eli Lilly, Jardiance, drug ads, DTC advertising
AstraZeneca, Boehringer cry 'no class effect' after Johnson & Johnson's Invokana doubles amputations in study
Fierce Pharma
Wed, 06/14/17 - 09:00 pm
Tags:
AstraZeneca, Boehringer Ingelheim, JNJ, Invokana, diabetes, Jardiance, amputation
J&J's Invokana lowers CV risk, but by enough to compete?
BioPharma Dive
Wed, 06/14/17 - 11:37 am
Tags:
JNJ, Invokana, diabetes, Jardiance, Eli Lilly, Boehringer Ingelheim
ADA: Merck, Pfizer notch success, but late with SGLT-2 data
BioPharma Dive
Tue, 06/13/17 - 12:15 pm
Tags:
diabetes, Merck, Pfizer, SGLT2 inhibitor, Januvia, Invokana, Farxiga, Jardiance, Eli Lilly, Boehringer Ingelheim, AstraZeneca, JNJ
J&J Drug Prevents Heart Attacks At Cost Of Amputated Toes
Forbes
Mon, 06/12/17 - 10:15 pm
Tags:
JNJ, heart attacks, Invokana, diabetes, amputation. Eli Lilly, Boehringer Ingelheim, Jardiance
ADA preview: 5 things to watch in diabetes
BioPharma Dive
Sun, 06/11/17 - 09:30 am
Tags:
ADA, diabetes, Jardiance, Eli Lilly, Boehringer Ingelheim, Lantus, Tresiba, JNJ, Novo Nordisk, PCSK9 inhibitors, Amgen Regeneron, Sanofi, Apple, Google, insulin
Boehringer Ingelheim opens large manufacturing facility in China
BioPharma Dive
Thu, 05/18/17 - 07:54 pm
Tags:
Boehringer Ingelheim, China, drug manufacturing
Pradaxa’s 'Red Fish' go to the aquarium in new Boehringer campaign
Fierce Pharma
Mon, 05/8/17 - 11:35 am
Tags:
Boehringer Ingelheim, Pradaxa, drug ads, television ads, bloodthinners
Boehringer eyes marked sales gain, boosted by animal health
Yahoo/Reuters
Thu, 04/6/17 - 09:26 am
Tags:
Boehringer Ingelheim, animal health, earnings

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.